Zepbound (tirzepatide) does not directly increase your basal metabolic rate like traditional stimulant medications
[DOI] [PubMed] [Google Scholar] Vafadar-Afshar G
I have even experienced subtle pushback after saying publicly that while I am not opposed to hormone therapy, my body is already in the middle of a significant transition, and I am not personally ready to add another variable into the mix
Harrison et al.: A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis (MAESTRO-NASH) nej.md/4bHd7iT Original Article by A.J
About this article Cite this article McGuire, F.P., Martinez, R., Lenz, A
Additionally, these agents favorably impact cardiovascular risk factors, including reductions in blood pressure and body weight, further enhancing kidney protection [27,28]